.Pharmacolibrary.Drugs.R_RespiratorySystem.R03C_AdrenergicsForSystemicUse.R03CB53_OrciprenalineCombination.OrciprenalineCombination .Pharmacolibrary.Drugs.R_RespiratorySystem.R03C_AdrenergicsForSystemicUse.R03CB53_OrciprenalineCombination.OrciprenalineCombination| name: | OrciprenalineCombinations |
| ATC code: | R03CB53 | route: | oral |
| n-compartments | 1 |
Orciprenaline, also known as metaproterenol, is a beta-2 adrenergic agonist used primarily as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). The ATC code R03CB53 refers to combinations of orciprenaline with other drugs. Use of orciprenaline as a single agent or in combinations has significantly declined in many countries due to the availability of newer and more selective agents, and in some regions it is no longer approved.
No peer-reviewed, population-specific pharmacokinetic data for orciprenaline in combinations under ATC R03CB53 has been found in the scientific literature. The following values are generalized estimates based on available data for single-agent orciprenaline oral administration in healthy adults.